Literature DB >> 12111644

Low frequency of MECP2 mutations in mentally retarded males.

Helger G Yntema1, Tjitske Kleefstra, Astrid R Oudakker, Tom Romein, Bert B A de Vries, Willy Nillesen, Erik A Sistermans, Han G Brunner, Ben C J Hamel, Hans van Bokhoven.   

Abstract

A high frequency of mutations in the methyl CpG-binding protein 2 (MECP2) gene has recently been reported in males with nonspecific X-linked mental retardation. The results of this previous study suggested that the frequency of MECP2 mutations in the mentally retarded population was comparable to that of CGG expansions in FMR1. In view of these data, we performed MECP2 mutation analysis in a cohort of 475 mentally retarded males who were negative for FMR1 CGG repeat expansion. Five novel changes, detected in seven patients, were predicted to change the MECP2 coding sequence. Except for one, these changes were not found in a control population. While this result appeared to suggest a high mutation rate, this conclusion was not supported by segregation studies. Indeed, three of the five changes could be traced in unaffected male family members. For another change, segregation analysis in the family was not possible. Only one mutation, a frameshift created by a deletion of two bases, was found to be de novo. This study clearly shows the importance of segregation analysis for low frequency mutations, in order to distinguish them from rare polymorphisms. The true frequency of MECP2 mutations in the mentally retarded has probably been overestimated. Based on our data, the frequency of MECP2 mutations in mentally retarded males is 0.2% (1/475).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12111644     DOI: 10.1038/sj.ejhg.5200836

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  7 in total

Review 1.  Rett syndrome: clinical review and genetic update.

Authors:  L S Weaving; C J Ellaway; J Gécz; J Christodoulou
Journal:  J Med Genet       Date:  2005-01       Impact factor: 6.318

2.  The array of clinical phenotypes of males with mutations in Methyl-CpG binding protein 2.

Authors:  Jeffrey L Neul; Timothy A Benke; Eric D Marsh; Steven A Skinner; Jonathan Merritt; David N Lieberman; Shannon Standridge; Timothy Feyma; Peter Heydemann; Sarika Peters; Robin Ryther; Mary Jones; Bernhard Suter; Walter E Kaufmann; Daniel G Glaze; Alan K Percy
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2018-12-07       Impact factor: 3.568

3.  MECP2 mutations in Czech patients with Rett syndrome and Rett-like phenotypes: novel mutations, genotype-phenotype correlations and validation of high-resolution melting analysis for mutation scanning.

Authors:  Daniela Zahorakova; Petra Lelkova; Vladimir Gregor; Martin Magner; Jiri Zeman; Pavel Martasek
Journal:  J Hum Genet       Date:  2016-03-17       Impact factor: 3.172

Review 4.  MECP2 mutations in males.

Authors:  Laurent Villard
Journal:  J Med Genet       Date:  2007-03-09       Impact factor: 6.318

5.  Macrocephalic mental retardation associated with a novel C-terminal MECP2 frameshift deletion.

Authors:  Konrad Oexle; Barbara Thamm-Mücke; Thomas Mayer; Sigrid Tinschert
Journal:  Eur J Pediatr       Date:  2004-11-19       Impact factor: 3.183

6.  X-chromosome inactivation patterns are unbalanced and affect the phenotypic outcome in a mouse model of rett syndrome.

Authors:  Juan I Young; Huda Y Zoghbi
Journal:  Am J Hum Genet       Date:  2004-02-17       Impact factor: 11.025

7.  MECP2 mutations or polymorphisms in mentally retarded boys: diagnostic implications.

Authors:  Violaine Bourdon; Christophe Philippe; Dominique Martin; Alain Verloès; Agnès Grandemenge; Philippe Jonveaux
Journal:  Mol Diagn       Date:  2003
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.